Kenji Hashimoto
#86,919
Most Influential Person Now
Researcher
Kenji Hashimoto's AcademicInfluence.com Rankings
Kenji Hashimotocomputer-science Degrees
Computer Science
#2933
World Rank
#3070
Historical Rank
Computational Linguistics
#81
World Rank
#83
Historical Rank
Machine Learning
#240
World Rank
#243
Historical Rank
Artificial Intelligence
#404
World Rank
#411
Historical Rank
Download Badge
Computer Science
Kenji Hashimoto's Degrees
- PhD Computer Science University of Tokyo
- Masters Artificial Intelligence Stanford University
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Kenji Hashimoto Influential?
(Suggest an Edit or Addition)Kenji Hashimoto's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Nervous system involvement after infection with COVID-19 and other coronaviruses (2020) (1528)
- Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants (2003) (1133)
- Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control (2020) (857)
- Increased Levels of Glutamate in Brains from Patients with Mood Disorders (2007) (558)
- Critical role of brain-derived neurotrophic factor in mood disorders (2004) (492)
- Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. (2003) (468)
- Immune Activation During Pregnancy in Mice Leads to Dopaminergic Hyperfunction and Cognitive Impairment in the Offspring: A Neurodevelopmental Animal Model of Schizophrenia (2006) (440)
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects (2015) (408)
- Brain‐derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions (2010) (366)
- Emerging role of glutamate in the pathophysiology of major depressive disorder (2009) (356)
- Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits (2004) (322)
- Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets (2016) (293)
- Knowledge and attitudes of medical staff in Chinese psychiatric hospitals regarding COVID-19 (2020) (263)
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine (2014) (246)
- Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients (2005) (244)
- Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. (1996) (242)
- Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation (2015) (235)
- Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder (2012) (230)
- Increased serum levels of glutamate in adult patients with autism (2006) (223)
- Current status of potential therapeutic candidates for the COVID-19 crisis (2020) (222)
- Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders (2013) (201)
- Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T 1H-MRS Study (2008) (190)
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective (2019) (184)
- Fabp7 Maps to a Quantitative Trait Locus for a Schizophrenia Endophenotype (2007) (181)
- Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine (2017) (178)
- Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration (2013) (173)
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression (2013) (165)
- d-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats (2008) (159)
- Mechanistic Target of Rapamycin–Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model (2018) (156)
- Alteration of Plasma Glutamate and Glutamine Levels in Children with High-Functioning Autism (2011) (152)
- Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders (2003) (152)
- Possible role of the gut microbiota–brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model (2017) (150)
- Identification of Multiple Serine Racemase (SRR) mRNA Isoforms and Genetic Analyses of SRR and DAO in Schizophrenia and d-Serine Levels (2005) (149)
- Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression (2015) (148)
- Bifidobacterium in the gut microbiota confer resilience to chronic social defeat stress in mice (2017) (147)
- Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls (2003) (146)
- The role of glutamate on the action of antidepressants (2011) (146)
- Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals. (2006) (146)
- Enhanced carbonyl stress in a subpopulation of schizophrenia. (2010) (144)
- Effect of antioxidant N-acetyl-l-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine (2004) (144)
- NMDA- and β-Amyloid1–42-Induced Neurotoxicity Is Attenuated in Serine Racemase Knock-Out Mice (2008) (141)
- Serum Interleukin-6 Is a Predictive Biomarker for Ketamine’s Antidepressant Effect in Treatment-Resistant Patients With Major Depression (2015) (140)
- Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol. (2005) (139)
- (R)-Ketamine Shows Greater Potency and Longer Lasting Antidepressant Effects Than Its Metabolite (2R,6R)-Hydroxynorketamine (2017) (133)
- Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine (2006) (131)
- Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth by Fluvoxamine: Role of Sigma-1 Receptors, IP3 Receptors and Cellular Signaling Pathways (2008) (130)
- Phencyclidine-Induced Cognitive Deficits in Mice are Improved by Subsequent Subchronic Administration of Fluvoxamine: Role of Sigma-1 Receptors (2007) (128)
- Synthesis and biological evaluation of D-amino acid oxidase inhibitors. (2008) (127)
- Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine (2009) (126)
- Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism (2006) (126)
- Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder (2007) (126)
- Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia (2002) (125)
- Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist (2015) (117)
- Decreased serum levels of transforming growth factor-β1 in patients with autism (2007) (116)
- Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut–microbiota–brain axis (2017) (116)
- Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress (2016) (116)
- High Occupancy of Sigma-1 Receptors in the Human Brain after Single Oral Administration of Fluvoxamine: A Positron Emission Tomography Study Using [11C]SA4503 (2007) (115)
- Phencyclidine-Induced Cognitive Deficits in Mice Are Improved by Subsequent Subchronic Administration of the Novel Selective α7 Nicotinic Receptor Agonist SSR180711 (2008) (112)
- Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression (2016) (111)
- Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites (2019) (111)
- Targeting of NMDA receptors in new treatments for schizophrenia (2014) (109)
- Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice (2016) (106)
- Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice (2013) (106)
- Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain–liver axis (2017) (105)
- Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients (2005) (105)
- α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer’s Disease (2010) (104)
- Minocycline Attenuates Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Administration of the NMDA Receptor Antagonist Dizocilpine (2007) (104)
- Roles of glutamate signaling in preclinical and/or mechanistic models of depression (2012) (104)
- Combined intoxication with methylone and 5-MeO-MIPT (2007) (102)
- Inflammatory Biomarkers as Differential Predictors of Antidepressant Response (2015) (102)
- Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine (2016) (101)
- Tropisetron improves deficits in auditory P50 suppression in schizophrenia (2005) (101)
- Cognition and depression: the effects of fluvoxamine, a sigma‐1 receptor agonist, reconsidered (2010) (100)
- Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain (2019) (99)
- Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline (2008) (99)
- Social Isolation-Induced Aggression Potentiates Anxiety and Depressive-Like Behavior in Male Mice Subjected to Unpredictable Chronic Mild Stress (2011) (98)
- Visualization of specific binding sites of benzodiazepine in human brain. (1986) (98)
- Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: A preliminary study (2010) (97)
- Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys (2016) (96)
- Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model (2017) (96)
- Computer-controlled large scale production of high specific activity [11C]RO 15-1788 for PET studies of benzodiazepine receptors. (1985) (95)
- Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson’s disease (2018) (95)
- Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship. (2009) (94)
- Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine. (2020) (93)
- Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: Role of sigma-1 receptors and IP3 receptors (2008) (92)
- Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells. (2014) (92)
- Glycine Transport Inhibitors for the Treatment of Schizophrenia (2010) (92)
- Regional Differences in Brain-Derived Neurotrophic Factor Levels and Dendritic Spine Density Confer Resilience to Inescapable Stress (2015) (91)
- Synthesis and evaluation of11C-PK 11195 forin vivo study of peripheral-type benzodiazepine receptors using position emission tomography (1989) (90)
- Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis (2016) (89)
- Potentiation of the NMDA receptor‐mediated responses through the activation of the glycine site by microglia secreting soluble factors (2006) (89)
- Association between brain‐derived neurotrophic factor 196 G/A polymorphism and personality traits in healthy subjects (2004) (89)
- Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: As a biological predictor of response to group cognitive behavioral therapy (2005) (88)
- Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine (2013) (88)
- Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine (2017) (88)
- Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders. (2015) (87)
- Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine (2019) (86)
- A historical review of antidepressant effects of ketamine and its enantiomers (2020) (85)
- Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline (2012) (84)
- Optimal Extent of Dopamine D2 Receptor Occupancy by Antipsychotics for Treatment of Dopamine Supersensitivity Psychosis and Late-Onset Psychosis (2013) (83)
- Further characterization of [3H]ifenprodil binding to σ receptors in rat brain (1993) (83)
- Prophylactic effects of sulforaphane on depression-like behavior and dendritic changes in mice after inflammation. (2017) (82)
- Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases. (2012) (82)
- Possible role of d-serine in the pathophysiology of Alzheimer's disease (2004) (81)
- BDNF variant linked to anxiety-related behaviors. (2007) (81)
- A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia (2010) (81)
- Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor (2021) (80)
- Levels of d-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice (2011) (80)
- Preliminary genome‐wide association study of bipolar disorder in the Japanese population (2009) (79)
- Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression (2016) (79)
- A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration (2020) (79)
- BDNF–TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms (2015) (79)
- Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands (2015) (78)
- AMPA Receptor Activation–Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine (2018) (78)
- An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia (2015) (78)
- Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine (2016) (77)
- (2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice (2018) (76)
- Orbitofrontal cortex abnormality and deficit schizophrenia (2013) (76)
- Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping α7 nicotinic receptors by positron emission tomography (2009) (76)
- Dysfunction of Glia-Neuron Communication in Pathophysiology of Schizophrenia (2005) (75)
- Magnetic resonance spectroscopy study of the antioxidant defense system in schizophrenia. (2011) (75)
- Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication. (2015) (74)
- Association between the brain‐derived neurotrophic factor 196G/A polymorphism and eating disorders (2004) (74)
- An update on ketamine and its two enantiomers as rapid-acting antidepressants (2018) (73)
- Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts. (2014) (72)
- Brain-derived neurotrophic factor (BDNF) and set-shifting in currently ill and recovered anorexia nervosa (AN) patients (2008) (71)
- The role of sigma-1 receptors in the pathophysiology of neuropsychiatric diseases (2009) (70)
- Prevalence of PTSD and Depression among Junior Middle School Students in a Rural Town Far from the Epicenter of the Wenchuan Earthquake in China (2012) (70)
- Protective Effects of N-acetyl-L-cysteine on the Reduction of Dopamine Transporters in the Striatum of Monkeys Treated with Methamphetamine (2004) (68)
- Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain. (2006) (68)
- Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder (2016) (68)
- Further characterization of [3H]ifenprodil binding in rat brain. (1994) (67)
- Maternal glyphosate exposure causes autism-like behaviors in offspring through increased expression of soluble epoxide hydrolase (2020) (67)
- Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis (2011) (67)
- Altered Dendritic Morphology of Purkinje cells in Dyt1 ΔGAG Knock-In and Purkinje Cell-Specific Dyt1 Conditional Knockout Mice (2011) (67)
- Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model (2016) (66)
- Targeting of NMDA receptors in the treatment of major depression. (2014) (66)
- Ingestion of Lactobacillus intestinalis and Lactobacillus reuteri causes depression- and anhedonia-like phenotypes in antibiotic-treated mice via the vagus nerve (2020) (66)
- Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: A retrospective cohort study (2020) (66)
- Role of brain-derived neurotrophic factor in eating disorders: Recent findings and its pathophysiological implications (2005) (66)
- Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor (2021) (66)
- Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and d-serine (2008) (64)
- Role of Actinobacteria and Coriobacteriia in the antidepressant effects of ketamine in an inflammation model of depression (2019) (64)
- Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia (2011) (63)
- Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant (2016) (63)
- The cognitive impairments and psychological wellbeing of methamphetamine dependent patients compared with health controls (2016) (63)
- Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: role of alpha7 nicotinic receptors. (2006) (63)
- Destruction of Dopaminergic Neurons in the Midbrain by 6-Hydroxydopamine Decreases Hippocampal Cell Proliferation in Rats: Reversal by Fluoxetine (2010) (62)
- Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression (2017) (62)
- Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: Role of sigma-1 receptors (2009) (62)
- Relationship between perception and anxiety about COVID-19 infection and risk behaviors for spreading infection: A national survey in Japan (2020) (62)
- Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at Adulthood (2015) (61)
- Protective Effects of Minocycline on the Reduction of Dopamine Transporters in the Striatum After Administration of Methamphetamine: A Positron Emission Tomography Study in Conscious Monkeys (2007) (60)
- Abnormality in glutamine–glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study (2016) (60)
- Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of α7 nicotinic acetylcholine receptors (2005) (59)
- High occupancy of sigma1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503. (2009) (59)
- Essential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future Perspective (2018) (59)
- Abnormal composition of gut microbiota is associated with resilience versus susceptibility to inescapable electric stress (2019) (59)
- [11C]CHIBA-1001 as a Novel PET Ligand for α7 Nicotinic Receptors in the Brain: A PET Study in Conscious Monkeys (2008) (58)
- Regional differences in the expression of brain-derived neurotrophic factor (BDNF) pro-peptide, proBDNF and preproBDNF in the brain confer stress resilience (2016) (58)
- Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: Role of serotonin 5-HT1A receptors (2008) (58)
- Infusions of allopregnanolone into the hippocampus and amygdala, but not into the nucleus accumbens and medial prefrontal cortex, produce antidepressant effects on the learned helplessness rats (2011) (58)
- Glutamate Hypothesis of Schizophrenia and Approach for Possible Therapeutic Drugs (2004) (57)
- Ketamine’s antidepressant action: beyond NMDA receptor inhibition (2016) (57)
- Behavioral changes and expression of heat shock protein hsp-70 mRNA, brain-derived neurotrophic factor mRNA, and cyclooxygenase-2 mRNA in rat brain following seizures induced by systemic administration of kainic acid (1998) (55)
- Association study between brain‐derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan (2005) (55)
- Glycine transporter-1: a new potential therapeutic target for schizophrenia. (2011) (54)
- Brain–gut–microbiota axis in depression: A historical overview and future directions (2022) (54)
- Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF) and Its Precursor proBDNF in Healthy Subjects (2012) (54)
- Alterations in the inflammatory cytokines and brain-derived neurotrophic factor contribute to depression-like phenotype after spared nerve injury: improvement by ketamine (2017) (54)
- Antibiotic-induced microbiome depletion is associated with resilience in mice after chronic social defeat stress. (2019) (54)
- A Series of d-Amino Acid Oxidase Inhibitors Specifically Prevents and Reverses Formalin-Induced Tonic Pain in Rats (2011) (54)
- Roles of endogenous glutathione levels on 6-hydroxydopamine-induced apoptotic neuronal cell death in human neuroblastoma SK-N-SH cells (2002) (54)
- Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth in PC12 Cells by Ifenprodil: The Role of Sigma-1 and IP3 Receptors (2012) (53)
- Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: initial findings. (2015) (53)
- A role of the subdiaphragmatic vagus nerve in depression-like phenotypes in mice after fecal microbiota transplantation from Chrna7 knock-out mice with depression-like phenotypes (2021) (53)
- Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans (2010) (53)
- Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders (2019) (52)
- Glycine and d-serine, but not d-cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801 (2008) (52)
- A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia (2014) (52)
- Mechanisms of action of fluvoxamine for COVID-19: a historical review (2022) (52)
- Letter to the Editor: R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity (2016) (51)
- Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine (2021) (51)
- Keap1–Nrf2 signaling pathway confers resilience versus susceptibility to inescapable electric stress (2018) (51)
- Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice. (2016) (51)
- α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophrenia. (2011) (51)
- Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1 (2020) (50)
- Depression-like phenotype by deletion of α7 nicotinic acetylcholine receptor: Role of BDNF-TrkB in nucleus accumbens (2016) (50)
- Interactions of erythro-ifenprodil, threo-ifenprodil, erythro-iodoifenprodil, and eliprodil with subtypes of sigma receptors. (1995) (49)
- Lack of Opioid System in the Antidepressant Actions of Ketamine (2019) (49)
- Omega-3 fatty acids for secondary prevention of posttraumatic stress disorder after accidental injury: an open-label pilot study. (2010) (49)
- A Novel Target of Action of Minocycline in NGF-Induced Neurite Outgrowth in PC12 Cells: Translation Initiation Factor eIF4AI (2010) (48)
- Personality Traits as Risk Factors for Treatment-Resistant Depression (2013) (48)
- Low Openness on the Revised NEO Personality Inventory as a Risk Factor for Treatment-Resistant Depression (2013) (48)
- Serum glutamine, set-shifting ability and anorexia nervosa (2010) (48)
- Changes in plasma d-serine, l-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment (2014) (47)
- A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis (2014) (47)
- Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammation (2016) (47)
- Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine (2012) (46)
- Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling (2016) (46)
- Decreased expression of reelin receptor VLDLR in peripheral lymphocytes of drug-naive schizophrenic patients (2008) (46)
- Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker (2015) (46)
- Tropisetron and its targets in Alzheimer’s disease (2015) (45)
- Regional differences in dendritic spine density confer resilience to chronic social defeat stress (2017) (45)
- α7 Nicotinic Receptor Agonists as Potential Therapeutic Drugs for Schizophrenia (2005) (45)
- Glycine transporter inhibitors as therapeutic agents for schizophrenia. (2006) (45)
- Effects of Brilliant Blue G on Serum Tumor Necrosis Factor-α Levels and Depression-like Behavior in Mice after Lipopolysaccharide Administration (2014) (45)
- Effects of the Antioxidant Sulforaphane on Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Phencyclidine Administration (2012) (44)
- No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder (2005) (44)
- (R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties. (2006) (44)
- Increased levels of serum basic fibroblast growth factor in schizophrenia (2003) (44)
- Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine (2011) (44)
- Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine‐induced cognitive deficits in mice (2013) (44)
- Decreased levels of serum oxytocin in pediatric patients with Attention Deficit/Hyperactivity Disorder (2015) (43)
- Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine (2015) (43)
- Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R,S)-ketamine and (S)-ketamine, but not (R)-ketamine (2018) (43)
- Brain-derived neurotrophic factor (BDNF) and its precursor proBDNF as diagnostic biomarkers for major depressive disorder and bipolar disorder (2015) (43)
- Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders. (2017) (43)
- (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism (2019) (43)
- Ingestion of Faecalibaculum rodentium causes depression-like phenotypes in resilient Ephx2 knock-out mice: A role of brain-gut-microbiota axis via the subdiaphragmatic vagus nerve. (2021) (43)
- Increased serum levels of serine enantiomers in patients with depression (2015) (43)
- Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain (2019) (43)
- A functional glutathione S‐transferase P1 gene polymorphism is associated with methamphetamine‐induced psychosis in Japanese population (2005) (43)
- 5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model (2017) (42)
- Association study between the genetic polymorphisms of glutathione‐related enzymes and schizophrenia in a Japanese population (2009) (42)
- Role of Brain-Derived Neurotrophic Factor in Beneficial Effects of Repetitive Transcranial Magnetic Stimulation for Upper Limb Hemiparesis after Stroke (2016) (42)
- Decreased Serum Levels of Platelet-Endothelial Adhesion Molecule (PECAM-1) in Subjects with High-Functioning Autism: A Negative Correlation with Head Circumference at Birth (2007) (41)
- Irradiation in Adulthood as a New Model of Schizophrenia (2008) (41)
- No change between the serum brain-derived neurotrophic factor in female patients with anorexia nervosa before and after partial weight recovery (2006) (41)
- Abnormal composition of gut microbiota contributes to delirium‐like behaviors after abdominal surgery in mice (2019) (41)
- Modulation of d-Serine Levels in Brains of Mice Lacking PICK1 (2008) (41)
- High-affinity [3H]6-nitroquipazine binding sites in rat brain. (1990) (41)
- Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram. (1996) (40)
- Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration (2016) (40)
- Potential Role of Brain-Derived Neurotrophic Factor in Omega–3 Fatty Acid Supplementation to Prevent Posttraumatic Distress after Accidental Injury: An Open-Label Pilot Study (2011) (40)
- Effect of the acute and chronic administration of the selective 5‐HT6 receptor antagonist SB‐271046 on the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study (2004) (40)
- Deficits in auditory P50 inhibition in obsessive–compulsive disorder (2008) (39)
- Rapid antidepressant effects and abuse liability of ketamine (2014) (39)
- Intake of 7,8-Dihydroxyflavone During Juvenile and Adolescent Stages Prevents Onset of Psychosis in Adult Offspring After Maternal Immune Activation (2016) (39)
- The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice (2012) (39)
- Peripheral interleukin-6 promotes resilience versus susceptibility to inescapable electric stress (2015) (39)
- Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model (2016) (39)
- Posterior cingulate gyrus metabolic changes in chronic schizophrenia with generalized cognitive deficits. (2007) (38)
- Decreased Serum Levels of Epidermal Growth Factor in Adult Subjects with High-Functioning Autism (2007) (38)
- Enzymes in the glutamate-glutamine cycle in the anterior cingulate cortex in postmortem brain of subjects with autism (2013) (38)
- Longitudinal Changes in Serum Brain-Derived Neurotrophic Factor in Accident Survivors with Posttraumatic Stress Disorder (2013) (38)
- Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders (2020) (38)
- Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats. (1995) (37)
- Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand. (2005) (37)
- 7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine (2013) (37)
- The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression (2014) (37)
- Role of the NMDA receptor in cognitive deficits, anxiety and depressive-like behavior in juvenile and adult mice after neonatal dexamethasone exposure (2014) (37)
- Serotonin activates presynaptic and postsynaptic receptors in rat globus pallidus. (2008) (37)
- Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology (2019) (37)
- Effects of brexpiprazole, a novel serotonin-dopamine activity modulator, on phencyclidine-induced cognitive deficits in mice: A role for serotonin 5-HT1A receptors (2014) (36)
- Reduced Mismatch Negativity is Associated with Increased Plasma Level of Glutamate in First-episode Psychosis (2017) (36)
- Improvement of dizocilpine-induced social recognition deficits in mice by brexpiprazole, a novel serotonin–dopamine activity modulator (2015) (36)
- Dietary restriction changes behaviours in brain‐derived neurotrophic factor heterozygous mice: role of serotonergic system (2006) (36)
- Effect of acute and chronic administration of the selective 5‐HT2C receptor antagonist SB‐243213 on midbrain dopamine neurons in the rat: An in vivo extracellular single cell study (2002) (36)
- Effect of chronic haloperidol treatment on synaptic protein mRNAs in the rat brain. (1998) (36)
- Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls (2015) (36)
- Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway (2010) (36)
- Muscle Atrophy and Motor Neuron Degeneration in Human NEDL1 Transgenic Mice (2010) (35)
- Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model (2019) (35)
- Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation (2018) (35)
- Neuropeptide S attenuates neuropathological, neurochemical and behavioral changes induced by the NMDA receptor antagonist MK-801 (2010) (35)
- Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model (2018) (35)
- Alterations in serum amino acid concentrations in male and female schizophrenic patients. (2007) (34)
- In Vivo Evaluation of α7 Nicotinic Acetylcholine Receptor Agonists [11C]A-582941 and [11C]A-844606 in Mice and Conscious Monkeys (2010) (34)
- Alterations in biodistribution of [3H]Ro 15-1788 in mice by acute stress: possible changes in in vivo binding availability of brain benzodiazepine receptor. (1985) (34)
- Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: A possible role of α1-adrenoceptors (2009) (33)
- MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling (2019) (33)
- Detrimental Side Effects of Repeated Ketamine Infusions in the Brain. (2016) (33)
- Association analyses between brain‐expressed fatty‐acid binding protein (FABP) genes and schizophrenia and bipolar disorder (2010) (33)
- Recent development of radioligands for imaging α7 nicotinic acetylcholine receptors in the brain. (2010) (33)
- Microglial activation in schizophrenia and minocycline treatment (2008) (33)
- Determination of kynurenic acid in human serum and its correlation with the concentration of certain amino acids. (2007) (33)
- Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine. (2000) (33)
- Effects of amycenone on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration (2015) (32)
- Synthesis and evaluation of 11C-PK 11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography. (1989) (32)
- Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine (2009) (32)
- Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents (2021) (32)
- Induction of heat shock protein (HSP)‐70 in posterior cingulate and retrosplenial cortex of rat brain by dizocilpine and phencyclidine: lack of protective effects of s receptor ligands (1996) (32)
- The NMDA Receptor Hypofunction Hypothesis for Schizophrenia and Glycine Modulatory Sites on the NMDA Receptors as Potential Therapeutic Drugs (2006) (32)
- Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis. (2007) (32)
- Neuropharmacological Profile of a Novel Potential Atypical Antipsychotic Drug Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)- 6H-[1]benzothieno[2,3-b][1,5] benzodiazepine maleate) (2002) (31)
- Effects of TrkB agonist 7,8-dihydroxyflavone on sensory gating deficits in mice after administration of methamphetamine (2013) (31)
- No changes in serum ghrelin levels in female patients with bulimia nervosa (2004) (31)
- Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial. (2015) (31)
- Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus (2017) (31)
- Biodistribution and radiation dosimetry of the α7 nicotinic acetylcholine receptor ligand [11C]CHIBA-1001 in humans. (2011) (31)
- Effects of Age and Gender on the Expression of Brain-Derived Neurotrophic Factor mRNA in Rat Retrosplenial Cortex Following Administration of Dizocilpine (2001) (31)
- Criterion and Construct Validity of the CogState Schizophrenia Battery in Japanese Patients with Schizophrenia (2011) (31)
- Supplementation with D-serine prevents the onset of cognitive deficits in adult offspring after maternal immune activation (2016) (31)
- Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia (2008) (31)
- Potentiation of nerve growth factor-induced neurite outgrowth by the ROCK inhibitor Y-27632: a possible role of IP₃ receptors. (2010) (30)
- Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics (2016) (30)
- Neurite outgrowth mediated by the heat shock protein Hsp90α: a novel target for the antipsychotic drug aripiprazole (2012) (30)
- The Tachikawa cohort of motor vehicle accident study investigating psychological distress: design, methods and cohort profiles (2009) (30)
- Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation (2019) (30)
- A Randomized, Double-Blind, Placebo-Controlled Trial of Fluvoxamine in Patients With Schizophrenia: A Preliminary Study (2012) (30)
- Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine (2019) (30)
- (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression (2020) (30)
- Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral Abnormalities in Adulthood: Clinical Rescue by D-Serine (2013) (29)
- Reliability and Validity of the CogState Battery Chinese Language Version in Schizophrenia (2013) (29)
- Metabolomics of Major Depressive Disorder and Bipolar Disorder: Overview and Future Perspective. (2018) (29)
- Association between sigma-1 receptor gene polymorphism and prefrontal hemodynamic response induced by cognitive activation in schizophrenia (2009) (29)
- Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model (2018) (29)
- A pilot double-blind comparison of d-serine and high-dose olanzapine in treatment-resistant patients with schizophrenia (2013) (29)
- Impaired processing speed and attention in first-episode drug naive schizophrenia with deficit syndrome (2014) (28)
- Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia (2014) (28)
- (R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation (2021) (28)
- Interactions of the potent d-amino acid oxidase inhibitor CBIO with morphine in pain and tolerance to analgesia (2012) (28)
- Arketamine, a new rapid-acting antidepressant: A historical review and future directions (2022) (28)
- What Are the Causes for Discrepancies of Antidepressant Actions of (2R,6R)-Hydroxynorketamine? (2017) (28)
- Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings (2019) (28)
- Association between the glutathione S‐transferase M1 gene deletion and female methamphetamine abusers (2004) (28)
- Is (S)-norketamine an alternative antidepressant for esketamine? (2018) (28)
- Role of NMDA receptor GluN2D subunit in the antidepressant effects of enantiomers of ketamine. (2017) (27)
- Increased midkine levels in sera from patients with Alzheimer's disease (2005) (27)
- Memantine induces heat shock protein HSP70 in the posterior cingulate cortex, retrosplenial cortex and dentate gyrus of rat brain (1996) (27)
- A case of methamphetamine use disorder treated with the antibiotic drug minocycline. (2010) (27)
- Disruption of reelin signaling attenuates methamphetamine‐induced hyperlocomotion (2007) (27)
- Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine: Role of BDNF-TrkB signaling (2019) (27)
- Decreased levels of free d-aspartic acid in the forebrain of serine racemase (Srr) knock-out mice (2013) (26)
- Role of Keap1-Nrf2 Signaling in Anhedonia Symptoms in a Rat Model of Chronic Neuropathic Pain: Improvement With Sulforaphane (2018) (26)
- Increased EphA4-ephexin1 signaling in the medial prefrontal cortex plays a role in depression-like phenotype (2017) (26)
- Prostaglandins and Other Lipid Mediators Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases. (2019) (26)
- (R)-Ketamine Rapidly Ameliorates the Decreased Spine Density in the Medial Prefrontal Cortex and Hippocampus of Susceptible Mice After Chronic Social Defeat Stress (2019) (26)
- Decreased susceptibility to seizures induced by pentylenetetrazole in serine racemase knockout mice (2012) (26)
- Possible involvement of brain‐derived neurotrophic factor in eating disorders (2012) (26)
- Recent topics on pharmacotherapy for amphetamine-type stimulants abuse and dependence. (2010) (25)
- Dynamic changes in AP-1 transcription factor DNA binding activity in rat brain following administration of antidepressant amitriptyline and brain-derived neurotrophic factor (2003) (25)
- Dopaminergic hypofunctions and prepulse inhibition deficits in mice lacking midkine (2009) (25)
- Orally active glutamate carboxypeptidase II inhibitor 2-MPPA attenuates dizocilpine-induced prepulse inhibition deficits in mice (2011) (25)
- Antidepressant effects of TBE-31 and MCE-1, the novel Nrf2 activators, in an inflammation model of depression. (2016) (25)
- Schizophrenia-Like Dopamine Release Abnormalities in a Mouse Model of NMDA Receptor Hypofunction (2018) (25)
- Improvement of Phencyclidine-Induced Cognitive Deficits in Mice by Subsequent Subchronic Administration of Fluvoxamine, but not Sertraline (2009) (25)
- In vivo labeling of sigma receptors in mouse brain with [3H]4‐phenyl‐1‐(4‐phenylbutyl)piperidine (1995) (25)
- Acute and repeated administration of the selective 5‐HT2A receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: An in vivo electrophysiological study (2001) (25)
- Deficits in emotion based decision-making in schizophrenia; a new insight based on the Iowa Gambling Task (2015) (24)
- Alterations of the daily rhythms of HPT axis induced by chronic unpredicted mild stress in rats (2015) (24)
- High affinity binding of [3H]6-nitroquipazine to cortical membranes in the rat: Inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors (1991) (24)
- Gold-catalyzed intermolecular addition of alcohols toward the allenic bond of 4-vinylidene-2-oxazolidinones. (2008) (24)
- Kinetics of [11C]N,N-dimethylphenylethylamine in mice and humans: potential for measurement of brain MAO-B activity. (1987) (24)
- Impact of aerobic exercise on cognitive impairment and oxidative stress markers in methamphetamine-dependent patients (2018) (24)
- Suppression of oro-facial movements by rolipram, a cAMP phosphodiesterase inhibitor, in rats chronically treated with haloperidol. (1995) (24)
- Decreased serum levels of hepatocyte growth factor in male adults with high-functioning autism (2007) (24)
- Brain-spleen axis in health and diseases: A review and future perspective (2022) (24)
- Effects of D-amino acid oxidase inhibitor on the extracellular D-alanine levels and the efficacy of D-alanine on dizocilpine-induced prepulse inhibition deficits in mice (2009) (24)
- Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling (2020) (24)
- Postischemic Brain Injury Is Affected Stereospecifically by Pentazocine in Rats (1997) (24)
- Lack of association between angiotensin I-converting enzyme insertion/deletion gene functional polymorphism and panic disorder in humans (2004) (23)
- Occupancy of α7 Nicotinic Acetylcholine Receptors in the Brain by Tropisetron: A Positron Emission Tomography Study Using [11C]CHIBA-1001 in Healthy Human Subjects (2011) (23)
- Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin–dopamine activity modulator: A role for serotonin 5-HT1A and 5-HT2A receptors (2015) (23)
- Slow oscillatory activity of rat globus pallidus neurons in vitro (2006) (23)
- Synthesis and evaluation of [11C]cyanoimipramine. (1987) (23)
- Characterization of [3H]CHIBA-1001 binding to α7 nicotinic acetylcholine receptors in the brain from rat, monkey, and human (2010) (23)
- Glutamatergic system abnormalities in posttraumatic stress disorder (2015) (23)
- Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study (2014) (23)
- Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol (2004) (23)
- Maintenance electroconvulsive therapy (ECT) for treatment-resistant disorganized schizophrenia (2007) (23)
- Serum Oxytocin, Posttraumatic Coping and C-Reactive Protein in Motor Vehicle Accident Survivors by Gender (2015) (23)
- 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation. (2000) (23)
- Ifenprodil for the Treatment of Flashbacks in Female Posttraumatic Stress Disorder Patients with a History of Childhood Sexual Abuse (2012) (23)
- Serum levels of P-selectin in men with high-functioning autism (2008) (22)
- The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone. (2000) (22)
- In vivo labeling of 5-hydroxytryptamine uptake sites in mouse brain with [3H]-6-nitroquipazine. (1990) (22)
- Functional polymorphism of the NQO2 gene is associated with methamphetamine psychosis (2005) (22)
- A new gluco indole alkaloid, 3, 4-dehydro-5-carboxystrictosidine, from Peruvian Uña de Gato (Uncaria tomentosa). (2000) (22)
- Depressive-like behavior in adrenocorticotropic hormone-treated rats blocked by memantine (2012) (22)
- A novel balanced chromosomal translocation found in subjects with schizophrenia and schizotypal personality disorder: Altered l-serine level associated with disruption of PSAT1 gene expression (2011) (22)
- Potentiation of NGF-induced neurite outgrowth in PC12 cells by papaverine: Role played by PLC-γ, IP3 receptors (2011) (22)
- Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia? (2009) (22)
- Brain Imaging of Nicotinic Receptors in Alzheimer's Disease (2010) (21)
- Impaired visual, working, and verbal memory in first-episode, drug-naive patients with major depressive disorder in a Chinese population (2018) (21)
- Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain (1992) (21)
- The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats (2001) (21)
- Two new nor-triterpene glycosides from peruvian "Uña de Gato" (Uncaria tomentosa). (2003) (21)
- Protective effect of the antipsychotic drug zotepine on dizocilpine-induced neuropathological changes in rat retrosplenial cortex. (2003) (21)
- Soluble epoxide hydrolase: a new therapeutic target for depression (2016) (21)
- Synthesis and SAR of 1-hydroxy-1H-benzo[d]imidazol-2(3H)-ones as Inhibitors of D-Amino Acid Oxidase. (2012) (21)
- Increased Levels of C1q in the Prefrontal Cortex of Adult Offspring after Maternal Immune Activation: Prevention by 7,8-Dihydroxyflavone (2017) (21)
- Effects of (R)-ketamine on reduced bone mineral density in ovariectomized mice: A role of gut microbiota (2022) (21)
- Neurite Outgrowth Mediated by Translation Elongation Factor eEF1A1: A Target for Antiplatelet Agent Cilostazol (2011) (21)
- The effects of dentate granule cell destruction on behavioural activity and Fos protein expression induced by systemic methamphetamine in rats (2001) (20)
- Involvement of dopamine D1 receptors in phencyclidine-induced behavioral stimulation in rats. (1995) (20)
- (+)-3-[2-(Benzo[b]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as potent agonists for the alpha7 nicotinic acetylcholine receptor. (2004) (20)
- Betaine supplementation is associated with the resilience in mice after chronic social defeat stress: a role of brain-gut-microbiota axis. (2020) (20)
- Genetic examination of the PLXNA2 gene in Japanese and Chinese people with schizophrenia (2008) (20)
- Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors (2010) (20)
- Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial (2013) (20)
- (R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut–microbiota–brain axis (2022) (20)
- Role of the amygdalo-hippocampal transition area in the fear expression: evaluation by behavior and immediate early gene expression (2004) (20)
- Association and synergistic interaction between promoter variants of the DRD4 gene in Japanese schizophrenics (2006) (20)
- Synthesis of 3,3-Disubstituted Isoindolin-1-ones via Iodoamination of α-Substituted Secondary 2-Vinylbenzamides. (2006) (19)
- Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease (2010) (19)
- Role of Serine Racemase in Behavioral Sensitization in Mice after Repeated Administration of Methamphetamine (2012) (19)
- Deletion of serine racemase confers D-serine –dependent resilience to chronic social defeat stress (2018) (19)
- No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation Model (2018) (19)
- Reduction of [3H]6‐nitroquipazine‐labelled 5‐hydroxytryptamine uptake sites in rat brain by 3,4‐methylenedioxymethamphetamine (1990) (19)
- Effects of N‐Acetyl‐l‐Cysteine on the Reduction of Brain Dopamine Transporters in Monkey Treated with Methamphetamine (2004) (19)
- BDNF and proBDNF as biomarkers for bipolar disorder (2014) (19)
- The immunophilin ligand FK506 protects against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum (2005) (18)
- Plasma estradiol levels and antidepressant effects of omega-3 fatty acids in pregnant women (2020) (18)
- Increased expression of inwardly rectifying Kir4.1 channel in the parietal cortex from patients with major depressive disorder. (2019) (18)
- A BDNF Val66Met Polymorphism and Ketamine-induced Rapid Antidepressant Action (2012) (18)
- Increased Serum Levels of Oxytocin in ‘Treatment Resistant Depression in Adolescents (TRDIA)’ Group (2016) (18)
- Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects☆ (2016) (17)
- Nuclear factor of activated T cells 4 in the prefrontal cortex is required for prophylactic actions of (R)-ketamine (2022) (17)
- The Efficacy of Omega-3 Fatty Acids for Depressive Symptoms among Pregnant Women in Japan and Taiwan: A Randomized, Double-Blind, Placebo-Controlled Trial (SYNCHRO; NCT01948596) (2018) (17)
- Determination of rat brain kynurenic acid by column-switching HPLC with fluorescence detection. (2007) (17)
- Ifenprodil for the Treatment of Flashbacks in Adolescent Female Posttraumatic Stress Disorder Patients with a History of Abuse (2013) (17)
- Lack of Antidepressant Effects of Low-Voltage-Sensitive T-Type Calcium Channel Blocker Ethosuximide in a Chronic Social Defeat Stress Model: Comparison with (R)-Ketamine (2018) (17)
- A facile synthesis of 9-dialkylamino-9H-pyrrolo[1,2-a]indoles via iminium salts generated from 2-(pyrrol-1-yl)benzaldehydes and secondary amine hydrochlorides in the presence of NaI/TMSCl/Et3N (2006) (17)
- Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine (2013) (17)
- Blood d-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine (2014) (17)
- Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome (2015) (17)
- Correction: R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects (2020) (17)
- Enhancement of acoustic prepulse inhibition by contextual fear conditioning in mice is maintained even after contextual fear extinction (2010) (17)
- Adenosine A1 Receptor Agonists Block the Neuropathological Changes in Rat Retrosplenial Cortex after Administration of the NMDA Receptor Antagonist Dizocilpine (2004) (17)
- Neuronal brain injury after cerebral ischemic stroke is ameliorated after subsequent administration of (R)-ketamine, but not (S)-ketamine (2020) (16)
- Induction of Fos protein by 3,4‐ methylenedioxymethamphetamine (Ecstasy) in rat brain: regional differences in pharmacological manipulation (1997) (16)
- Abnormal composition of microbiota in the gut and skin of imiquimod-treated mice (2021) (16)
- Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study (2016) (16)
- Assessment of a multi-assay biological diagnostic test for mood disorders in a Japanese population (2016) (16)
- Old drug fluvoxamine, new hope for COVID-19 (2021) (16)
- No changes in serum epidermal growth factor levels in patients with schizophrenia (2005) (16)
- Association study between polymorphisms in glutathione‐related genes and methamphetamine use disorder in a Japanese population (2008) (16)
- Two New 19-Hydroxyursolic Acid-type Triterpenes from Peruvian ‘Uña de Gato’ (Uncaria tomentosa) (2000) (16)
- Does hypofrontality expand to global brain area in progression of schizophrenia?: A cross-sectional study between first-episode and chronic schizophrenia (2009) (16)
- Perception of and anxiety about COVID-19 infection and risk behaviors for spreading infection: an international comparison (2020) (16)
- Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder (2016) (16)
- Analysis of strain‐dependent prepulse inhibition points to a role for Shmt1 (SHMT1) in mice and in schizophrenia (2010) (16)
- New oleanan-type triterpene and cincholic acid glycosides from Peruvian "Uña de Gato" (Uncaria tomentosa). (2004) (16)
- Life-Threatening Abnormal Behavior Incidence in 10–19 Year Old Patients Administered Neuraminidase Inhibitors (2015) (16)
- Risk of psychosis after repeated intermittent administration of (S)-ketamine, but not (R)-ketamine, in mice. (2020) (16)
- G protein-coupled receptor kinase 6/β-arrestin 2 system in a rat model of dopamine supersensitivity psychosis (2015) (16)
- Differential levels of brain amino acids in rat models presenting learned helplessness or non-learned helplessness (2013) (16)
- Effect of the neurotoxic dose of methamphetamine on gene expression of parkin and Pael-receptors in rat striatum. (2003) (16)
- Lack of dopamine D1 receptors in the antidepressant actions of (R)-ketamine in a chronic social defeat stress model (2019) (15)
- Functional Polymorphism of the Glutathione Peroxidase 1 Gene Is Associated with Personality Traits in Healthy Subjects (2005) (15)
- Role of Inflammatory Bone Markers in the Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model (2018) (15)
- Can minocycline prevent the onset of Alzheimer's disease? (2011) (15)
- Cognitive Impairment That Is Induced by (R)-Ketamine Is Abolished in NMDA GluN2D Receptor Subunit Knockout Mice (2019) (15)
- Ethnic differences in the serum levels of proBDNF, a precursor of brain-derived neurotrophic factor (BDNF), in mood disorders (2016) (15)
- Brain-derived neurotrophic factor-TrkB signaling in the medial prefrontal cortex plays a role in the anhedonia-like phenotype after spared nerve injury (2018) (15)
- Regulation of brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain by serotonin (2016) (15)
- Dizocilpine-induced neuropathological changes in rat retrosplenial cortex are reversed by subsequent clozapine treatment. (2000) (15)
- Rapid Antidepressant Activity of Ketamine Beyond NMDA Receptor (2017) (15)
- New synthesis of isoquinoline and 3,4-dihydroisoquinoline derivatives (2006) (15)
- Two clusters of serum midkine levels in drug-naive patients with schizophrenia (2003) (15)
- Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia (2018) (15)
- Abnormal expression of colony stimulating factor 1 receptor (CSF1R) and transcription factor PU.1 (SPI1) in the spleen from patients with major psychiatric disorders: A role of brain-spleen axis. (2020) (14)
- Are NMDA and opioid receptors involved in the antidepressant actions of ketamine? (2020) (14)
- Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study (2014) (14)
- Comparison of rapid and long-lasting antidepressant effects of negative modulators of α5-containing GABAA receptors and (R)‑ketamine in a chronic social defeat stress model (2018) (14)
- Acute and chronic administration of the selective 5‐HT1A receptor antagonist WAY‐405 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study (1999) (14)
- An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients (2014) (14)
- Regionally different effects of scopolamine on NMDA antagonist-induced heat shock protein HSP70 (1997) (14)
- Effects of AS2586114, a soluble epoxide hydrolase inhibitor, on hyperlocomotion and prepulse inhibition deficits in mice after administration of phencyclidine (2013) (14)
- Neuropsychological Impairment and Its Association with Violence Risk in Japanese Forensic Psychiatric Patients: A Case-Control Study (2016) (14)
- [Major depressive disorders and BDNF (brain-derived neurotrophic factor)]. (2004) (14)
- Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects (2010) (14)
- Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine (2019) (14)
- Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors (2009) (14)
- The Influence of Age on the Outcomes of Traumatic Brain Injury: Findings from a Japanese Nationwide Survey (J-ASPECT Study-Traumatic Brain Injury). (2019) (13)
- Shortened protocol in practical [11C]SA4503-PET studies for sigma1 receptor quantification (2008) (13)
- Serum brain-derived neurotrophic factor and antidepressant-naive major depression after lung cancer diagnosis. (2011) (13)
- Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamine (1990) (13)
- Antidepressant Effects of Ketamine on Depression-like Behavior in Juvenile Mice after Neonatal Dexamethasone Exposure (2014) (13)
- Intake of 7,8-dihydroxyflavone from pregnancy to weaning prevents cognitive deficits in adult offspring after maternal immune activation (2017) (13)
- Increased expression of soluble epoxide hydrolase in the brain and liver from patients with major psychiatric disorders: A role of brain - liver axis. (2020) (13)
- (R)-Ketamine ameliorates lethal inflammatory responses and multi-organ injury in mice induced by cecum ligation and puncture. (2021) (13)
- A role of gut–microbiota–brain axis via subdiaphragmatic vagus nerve in depression-like phenotypes in Chrna7 knock-out mice (2022) (13)
- Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia (2015) (13)
- Serum neuropeptide Y in accident survivors with depression or posttraumatic stress disorder (2014) (13)
- Abnormalities of the glutamine–glutamate–GABA cycle in the schizophrenia brain (2014) (13)
- Abnormalities of the composition of the gut microbiota and short-chain fatty acids in mice after splenectomy (2021) (13)
- Fluvoxamine improved cognitive impairments in a patient with schizophrenia (2010) (12)
- Amantadine induces c-fos in rat striatum: reversal with dopamine D1 and NMDA receptor antagonists. (1995) (12)
- Sigma-1 receptor agonist fluvoxamine for delirium in intensive care units: report of five cases (2010) (12)
- Fecal microbiota transplantation from patients with rheumatoid arthritis causes depression-like behaviors in mice through abnormal T cells activation (2022) (12)
- Recent Advances in Potential Therapeutic Drugs for Cognitive Impairment in Schizophrenia (2012) (12)
- Benefical Effects of Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia and Tardive Akathisia in Patients with Schizophrenia: Report of Three Cases (2013) (12)
- A role of microRNA-149 in the prefrontal cortex for prophylactic actions of (R)-ketamine in inflammation model (2022) (12)
- igh Occupancy of Sigma-1 Receptors in the Human rain after Single Oral Administration of Fluvoxamine : Positron Emission Tomography Study Using 11 C ] SA 4503 (2007) (12)
- Association between angiotensin I-converting enzyme insertion/deletion gene functional polymorphism and novelty seeking personality in healthy females (2006) (12)
- High-affinity binding of [3H]6-nitroquipazine to 5-hydroxytryptamine transporter in human platelets. (1990) (12)
- Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study (2017) (12)
- In vivo evaluation of carbon-11-labelled non-sarcosine-based glycine transporter 1 inhibitors in mice and conscious monkeys. (2011) (12)
- Glycine Transporter-1 Inhibitors as Novel Therapeutic Drugs for Schizophrenia (2007) (12)
- Impact of consuming green and yellow vegetables on the depressive symptoms of junior and senior high school students in Japan (2019) (12)
- Analysis of correlation between serum d-serine levels and functional promoter polymorphisms of GRIN2A and GRIN2B genes (2006) (12)
- Gamma-band auditory steady-state response is associated with plasma levels of d-serine in schizophrenia: An exploratory study (2019) (12)
- Is D-Cycloserine a Prodrug for D-Serine in the Brain? (2013) (12)
- Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker (2016) (11)
- Dextran sulfate sodium-induced inflammation and colitis in mice are ameliorated by (R)-ketamine, but not (S)-ketamine: A role of TrkB signaling. (2021) (11)
- Dietary intake of glucoraphanin during pregnancy and lactation prevents the behavioral abnormalities in the offspring after maternal immune activation (2020) (11)
- Preparation of [3H]6-nitroquipazine, a potent and selective 5-hydroxytryptamine uptake inhibitor. (1990) (11)
- Auditory-conditioned-fear-dependent c-Fos expression is altered in the emotion-related brain structures of Fyn-deficient mice. (2004) (11)
- Further characterization of [3H]ifenprodil binding to sigma receptors in rat brain. (1993) (11)
- Therapeutic implications for NMDA receptors in mood disorders (2013) (11)
- Evaluation of 3H-paroxetine as a radioligand for in vivo study of 5-hydroxytryptamine uptake sites in mouse brain. (1990) (11)
- Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortex (2003) (11)
- Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol (2018) (11)
- Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder (2019) (11)
- Decreased Levels of Serum Brain-Derived Neurotrophic Factor in Male Pediatric Patients with Depression (2011) (11)
- Allopregnanolone induces antidepressant-like effects through BDNF-TrkB signaling independent from AMPA receptor activation in a rat learned helplessness model of depression (2020) (11)
- Microglial depletion and abnormalities in gut microbiota composition and short-chain fatty acids in mice after repeated administration of colony stimulating factor 1 receptor inhibitor PLX5622 (2021) (11)
- The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report (2010) (11)
- Gold-Catalyzed StereoselectiveSynthesis of Di- or Trisubstituted Olefins Possessinga 1,4-Diene Framework via Intramolecular Allylation of Alkynes (2010) (11)
- Further analysis of microsatellite marker in the BDNF gene (2005) (10)
- Sigma-1 receptor agonist fluvoxamine for postoperative delirium in older adults: report of three cases (2010) (10)
- Synthesis of 4,5-diaminopyrrolo[1,2-a]quinoline derivatives by annulation of N,N-dialkyl[2-(pyrrol-1-yl)benzylidene]ammonium salts in the presence of an isocyanide (2006) (10)
- Old drug ifenprodil, new hope for PTSD with a history of childhood abuse (2013) (10)
- The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial (2016) (10)
- The gut–liver axis in sepsis: interaction mechanisms and therapeutic potential (2022) (10)
- Omega‐3 fatty acid supplementation for expectant mothers with depressive symptoms in Japan and Taiwan: An open‐label trial (2016) (10)
- Understanding depression: linking brain-derived neurotrophic factor, transglutaminase 2 and serotonin (2013) (10)
- Expression of Fos protein in rat brain following administration of a nicotinic acetylcholine receptor agonist epibatidine (1998) (10)
- Ketamine: anesthetic, psychotomimetic, antidepressant, or anthelmintic? (2022) (10)
- Peripheral IL-6 signaling: a promising therapeutic target for depression? (2015) (10)
- Autism-like Behaviors in Male Juvenile Offspring after Maternal Glyphosate Exposure (2021) (9)
- Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases (2010) (9)
- [Depression and BDNF]. (2006) (9)
- α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease~!2009-10-15~!2009-10-30~!2010-05-27~! (2010) (9)
- Pharmacological Characterization of [3H]CHIBA-3007 Binding to Glycine Transporter 1 in the Rat Brain (2011) (9)
- Induction of heat shock protein (HSP)-70 in posterior cingulate and retrosplenial cortex of rat brain by dizocilpine and phencyclidine: lack of protective effects of sigma receptor ligands. (1996) (9)
- The role of hippocampal KCNQ2 channel in antidepressant actions of ketamine (2022) (9)
- The recency ratio is associated with reduced CSF glutamate in late-life depression (2017) (9)
- Deuterium isotope effect of [11C1]N,N-dimethylphenethyl-amine-alpha,alpha-d2; reduction in metabolic trapping rate in brain. (1986) (9)
- Less Social Support for Patients With COVID-19: Comparison With the Experience of Nurses (2021) (9)
- Failure to confirm the association between the PIK4CA gene and schizophrenia in a Japanese population (2009) (9)
- Drug effects on distribution of [3H]3,4-methylenedioxymethamphetamine in mice. (1993) (9)
- Pharmacological characterization of [125I]CHIBA-1006 binding, a new radioligand for α7 nicotinic acetylcholine receptors, to rat brain membranes (2010) (9)
- 4-bromo-6-nitroquipazine: A new ligand for studying 5-hydroxytryptamine uptake sites in vivo (1992) (9)
- Opposite roles for neuropeptide S in the nucleus accumbens and bed nucleus of the stria terminalis in learned helplessness rats (2015) (9)
- The Piccolo Intronic Single Nucleotide Polymorphism rs13438494 Regulates Dopamine and Serotonin Uptake and Shows Associations with Dependence-Like Behavior in Genomic Association Study. (2015) (9)
- Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorder (2011) (9)
- Effects of add-on tipepidine on treatment-resistant depression: an open-label pilot trial (2015) (8)
- Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder". (2009) (8)
- Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia (2020) (8)
- Reply to: The hyperglutamatergic hypothesis of autism (2008) (8)
- [Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs]. (2002) (8)
- Sigma‐1 receptor agonist fluvoxamine for delirium in older adults (2012) (8)
- Beneficial effects of anti-RANKL antibody in depression-like phenotype, inflammatory bone markers, and bone mineral density in male susceptible mice after chronic social defeat stress (2019) (8)
- Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)‐ketamine, but not (S)‐ketamine (2020) (8)
- Erratum: Infusions of allopregnanolone into the hippocampus and amygdala, but not into the nucleus accumbens and medial prefrontal cortex, produce antidepressant effects on the learned helplessness rats (2013) (8)
- A facile synthesis of 1,1-disubstituted isoindoline derivatives by intramolecular iodoamination of 2-vinylbenzylamine derivatives (2007) (8)
- Altered serum level of matrix metalloproteinase‐9 and its association with decision‐making in eating disorders (2017) (8)
- Ketamine and its metabolites: Potential as novel treatments for depression (2022) (8)
- A Case Report of Suicide Attempt Caused by Acute and Transient Psychotic Disorder during the COVID-19 Outbreak (2020) (8)
- Expression of brain‐derived neurotrophic factor (BDNF) mRNA in rat retrosplenial cortex following administration of phencyclidine (1998) (8)
- R-(−)-ketamine modifies behavioral effects of morphine predicting efficacy as a novel therapy for opioid use disorder1 (2020) (8)
- Dietary intake of glucoraphanin prevents the reduction of dopamine transporter in the mouse striatum after repeated administration of MPTP (2019) (8)
- Prenatal immune activation and subsequent peripubertal stress as a new model of schizophrenia (2013) (8)
- Expression of cyclooxygenase-2 mRNA in rat retrosplenial cortex following administration of phencyclidine (1997) (8)
- Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report (2017) (8)
- Regulation of neurotoxicity in the striatum and colon of MPTP-induced Parkinson’s disease mice by gut microbiome (2021) (8)
- High-affinity [3H]6-nitroquipazine binding to the 5-hydroxytryptamine transport system in rat lung. (1991) (7)
- Long-lasting beneficial effects of maternal intake of sulforaphane glucosinolate on gut microbiota in adult offspring. (2022) (7)
- Antidepressant-like actions of the mGlu2/3 receptor antagonist TP0178894 in the chronic social defeat stress model: Comparison with escitalopram (2021) (7)
- 7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine (2013) (7)
- Soluble Epoxide Hydrolase as a Therapeutic Target for Neuropsychiatric Disorders (2022) (7)
- The Tachikawa cohort of motor vehicle accident study investigating psychological distress: design, methods and cohort profiles (2009) (7)
- Glyphosate exposure exacerbates the dopaminergic neurotoxicity in the mouse brain after repeated administration of MPTP (2020) (7)
- Serum brain-derived neurotrophic factor as a predictor of incident dementia. (2014) (7)
- [Minocycline as a therapeutic drug for methamphetamine use disorders]. (2008) (7)
- Increased expression of zif268 mRNA in rat retrosplenial cortex following administration of phencyclidine (1999) (7)
- (R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression (2022) (7)
- Comparative evaluation of two serotonin transporter ligands in the human brain: [11C](+)McN5652 and [11C]cyanoimipramine (2002) (7)
- Gut–microbiota–brain axis in the vulnerability to psychosis in adulthood after repeated cannabis exposure during adolescence (2022) (7)
- Synthesis of functionalized chromanes via a formal 〔3+3〕cycloaddition of allene sulfonamides to phenols (2010) (7)
- Stereochemistry of reduction of the C-24,25 double bond in the conversion of desmosterol into cholesterol (2003) (7)
- Risk of neuropsychiatric disorders in offspring of COVID-19-infected pregnant women and nutritional intervention (2020) (7)
- Synthesis of 1-Aminonaphthalene-2-carbonitrile Derivatives by the Reaction of 2-Vinylbenzonitriles with 2-Lithioacetonitrile (2008) (7)
- Alterations in amino acid levels in mouse brain regions after adjunctive treatment of brexpiprazole with fluoxetine: comparison with (R)-ketamine (2017) (7)
- Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders (2019) (7)
- Synthesis of 9,9‐Disubstituted 9H‐Pyrrolo[1,2‐a]indoles by Hydriodic Acid‐Catalyzed Cyclization of 1‐[2‐(1‐Aryl(or methyl)ethenyl)phenyl]‐1H‐pyrroles (2011) (7)
- Lack of neuroprotective effect of sigma receptor ligands in the neurotoxicity of p-chloroamphetamine in rat brain. (1995) (7)
- Does an Increase of Cyclic AMP Prevent Methamphetamine‐Induced Behavioral Sensitization in Rats? (1996) (7)
- Beneficial effects of the sigma-1 agonist fluvoxamine for tardive dyskinesia in patients with postpsychotic depressive disorder of schizophrenia: report of 5 cases. (2012) (7)
- Subchronic Treatment with Methamphetamine and Phencyclidine Differentially Alters the Adenosine A1 and A2A Receptors in the Prefrontal Cortex, Hippocampus, and Striatum of the Rat (2001) (6)
- Association of CACNA1C polymorphisms with serum BDNF levels in bipolar disorder (2019) (6)
- Decreased cell proliferation in the dentate gyrus of α7 nicotinic acetylcholine receptor heterozygous mice (2004) (6)
- Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression (2015) (6)
- Repeated intermittent administration of (R)-ketamine during juvenile and adolescent stages prevents schizophrenia-relevant phenotypes in adult offspring after maternal immune activation: a role of TrkB signaling (2022) (6)
- Acute effect of c-fos antisense oligodeoxynucleotide on hippocampal partial seizures elicited by electrical stimulation in rats (1997) (6)
- [Isotopic fractionation of iproniazid and isopropylhydrazine from their deuterated analogues and application for isotope dilution analysis by capillary gas chromatography]. (1991) (6)
- Effects of add-on cilostazol on cognition in patients with schizophrenia: an open-label pilot trial. (2011) (6)
- Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling (2021) (6)
- [Amyloid cascade hypothesis of Alzheimer's disease and alpha 7 nicotinic receptor]. (2002) (6)
- Brain-derived neurotrophic factor-TrkB signaling and the mechanism of antidepressant activity by ketamine in mood disorders (2020) (6)
- Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia (2006) (6)
- Synthesis of (Z)-2-[(Z)-3-Alkylideneisobenzofuran-1(3H)-ylidene] acetic Acid Derivatives by Sequential Coupling-Cyclization between 3-(2-Iodophenyl)-3-oxopropanoic Acid Derivatives and Terminal Alkynes (2008) (6)
- Changes in in vivo binding of 3H-Ro 15-1788 in mouse brain by reserpine. (1988) (6)
- In vivo regulation of serotonin 5-HT2A receptors in rat brain by subchronic administration of sigma receptor ligand NE-100. (1997) (5)
- Correction: A Novel Target of Action of Minocycline in NGF-Induced Neurite Outgrowth in PC12 Cells: Translation Initiation Factor eIF4AI (2010) (5)
- Blepharospasm associated with olanzapine: a case report (2004) (5)
- Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats (2017) (5)
- Ifenprodil for emotional incontinence in patients with vascular dementia: two case reports. (2012) (5)
- Induction of heat shock protein HSP-70 in rat retrosplenial cortex following administration of dextromethorphan. (1996) (5)
- Regarding “N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial” (2008) (5)
- Old drug tipepidine as new hope for children with ADHD (2015) (5)
- Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity (2022) (5)
- Effects of acute and chronic administration of methamphetamine or phencyclidine on plasma adrenocorticotropin, corticosterone and progesterone in rat (1999) (5)
- [Antibiotic drug minocycline: a potential therapeutic drug for methamphetamine-related disorders]. (2013) (5)
- Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major Depression (2015) (5)
- Abnormalities in the composition of the gut microbiota in mice after repeated administration of DREADD ligands (2021) (5)
- Post-traumatic Stress Disorder Symptoms in a Female Patient Following Repeated Teasing: Treatment with Gabapentin and Lamotrigine and the Possible Role of Sensitization (2014) (5)
- Comments on ‘The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia’ (2010) (5)
- (R)-ketamine ameliorates the progression of experimental autoimmune encephalomyelitis in mice (2021) (5)
- New Oleanan-Type Triterpene and Cincholic Acid Glycosides from Peruvian “Una de Gato” (Uncaria tomentosa). (2005) (5)
- Synthesis of (Z)-2-(2H-Isoquinolin-1-ylidene)acetamides by Iodine-Mediated Cyclization of (Z)-3-Amino-3-(2-vinylphenyl)propenamides (2007) (5)
- A New Gluco Indole Alkaloid, 3,4‐Dehydro‐5‐carboxystrictosidine, from Peruvian Una de Gato (Uncaria tomentosa). (2001) (5)
- Effects of benzylpiperazine derivatives on the acute effects of 3,4-methylenedioxymethamphetamine in rat brain (1993) (5)
- A key role of miR-132-5p in the prefrontal cortex for persistent prophylactic actions of (R)-ketamine in mice (2022) (5)
- Suppression of abnormal α-synuclein expression by activation of BDNF transcription ameliorates Parkinson’s disease-like pathology (2022) (5)
- Effects of spleen nerve denervation on depression-like phenotype, systemic inflammation, and abnormal composition of gut microbiota in mice after administration of lipopolysaccharide: A role of brain-spleen axis. (2022) (5)
- Key role of the gut–microbiota–brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain (2023) (4)
- Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine (2020) (4)
- Ifenprodil tartrate treatment of adolescents with post-traumatic stress disorder: A double-blind, placebo-controlled trial (2022) (4)
- A New Metabolism-Related Index Correlates with the Degree of Liver Fibrosis in Hepatitis C Virus-Positive Patients (2015) (4)
- Association study between the PIK4CA gene and methamphetamine use disorder in a Japanese population (2009) (4)
- Synthesis and Evaluation of [^ C]Cyanoimipramine (1988) (4)
- Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder. (2020) (4)
- Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. (2003) (4)
- The NMDA Receptors (2017) (4)
- Antipsychotic-like effects of a novel phosphodiesterase 10A inhibitor T-251 in rodents (2019) (4)
- Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: An open-label pilot study (2017) (4)
- Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine. (1992) (4)
- On the Eve of Upgrading Antidepressants: (R)-Ketamine and Its Metabolites (2016) (4)
- Deleterious effects of nervous system in the offspring following maternal SARS-CoV-2 infection during the COVID-19 pandemic (2022) (4)
- Efficacy of anticonvulsant ethosuximide for major depressive disorder: a randomized, placebo-control clinical trial (2020) (4)
- Study of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain using specific in vivo binding of [3H]6-nitroquipazine (1992) (4)
- Role of d-serine in the beneficial effects of repetitive transcranial magnetic stimulation in post-stroke patients (2020) (4)
- Effect of repetitive transcranial magnetic stimulation on the kynurenine pathway in stroke patients. (2020) (4)
- Increased BDNF-TrkB signaling in the nucleus accumbens plays a role in the risk for psychosis after cannabis exposure during adolescence (2019) (4)
- Antibiotic-induced microbiome depletion improves LPS-induced acute lung injury via gut-lung axis. (2022) (4)
- Deuterium Isotope Effect of ^ C_1-N,N-Dimethylphenethyl-amine-α,α-d_2 : Reduction in Metabolic Trapping Rate in Brain (1987) (4)
- Comments to behavioral tests for antidepressant-like actions of (2R,6R)–hydroxynorketamine by Bonaventura et al. (2022) (4)
- Antipsychotic-like effects of a novel phosphodiesterase 10A inhibitor MT-3014 in rats (2020) (4)
- YM90K, a selective‐amino‐3‐hydroxy5‐methyl‐4‐isoxazole propionate (AMPA) receptor antagonist, prevents induction of heat shock protein HSP ‐70 and hsp ‐70 mRNA in rat retrosplenial cortex by phencyclidine (1997) (4)
- Comparative evaluation of two serotonin transporter ligands in the human brain: [(11)C](+)McN5652 and [(11)C]cyanoimipramine. (2002) (4)
- A Study of Remitted and Treatment-Resistant Depression Using MMPI and Including Pessimism and Optimism Scales (2014) (4)
- Role of EphA4 signaling in the pathogenesis of amyotrophic lateral sclerosis and therapeutic potential of traditional Chinese medicine rhynchophylline (2015) (4)
- Impact of FAAH gene, hyperactivation in emotion processing brain regions and Lavender oil preparation Silexan in anxiety (2019) (4)
- Corrigendum to “Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism” [Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (2006) 1529–1531] (2007) (4)
- Gut–microbiota–brain axis by bile acids in depression (2022) (3)
- Effects of splenectomy on skin inflammation and psoriasis-like phenotype of imiquimod-treated mice (2022) (3)
- [Role of sigma-1 receptors in neural plasticity and in antipsychotic action]. (2010) (3)
- Comments to “Fluvoxamine and long COVID-19: a new role for sigma-1 receptor (S1R) agonists” by Khani and Entezari-Maleki (2022) (3)
- Ketamine: From Abused Drug to Rapid-Acting Antidepressant (2020) (3)
- Arketamine for cognitive impairment in psychiatric disorders (2023) (3)
- Reply to: Acute Stress Symptoms Do Not Worsen in Posttraumatic Stress Disorder and Abuse with a Single Subanesthetic Dose of Ketamine (2013) (3)
- Effects of repeated electroconvulsive shocks on dopamine supersensitivity psychosis model rats (2021) (3)
- Reversal of acute effects of 3,4-methylenedioxymethamphetamine in rat brain by 1-piperonylpiperazine (1992) (3)
- A Bibliometric Analysis of Research on the Role of BDNF in Depression and Treatment (2022) (3)
- The Toll-like receptor 4 antagonist TAK-242 induces antidepressant-like effects in a rat learned helplessness model of depression through BDNF-TrkB signaling and AMPA receptor activation (2022) (3)
- High occupancy of s 1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography (2009) (3)
- Synthesis of racemic, S(+)‐ and R(‐)‐N‐[methyl‐3H]3,4‐methylenedioxymethamphetamine (1990) (3)
- Radiosynthesis of [18F]N-(4-phenylbutyl)-4-(4-fluorobenzoyl)piperidine for studying serotonin 5-HT2A receptors (1998) (3)
- Mood, psychomotor, and cognitive function in major depressive disorder: from biomarkers to rapid-acting antidepressants (2019) (3)
- Significance of ionization-track contribution to self-quenching streamer (SQS) formation induced by alpha-rays (1992) (3)
- [A study of the benzodiazepine receptor in the human brain using 11C-Ro 15-1788 and positron emission tomography]. (1985) (3)
- [Evaluation of 3H-PK11195 as a radioligand for the in vivo study of peripheral benzodiazepine receptor]. (1985) (3)
- Impact of age on optimal dose of antidepressants (2020) (3)
- Study of D-serine function in vivo by establishing and analysis of serine racemase knockout mouse (2007) (3)
- Current Status of Substance Abuse in East Asia and Therapeutic Prospects. (2016) (3)
- Enhancement of prepulse inhibition by fear conditioning in mice (2009) (3)
- Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice (2022) (3)
- Two New 19-Hydroxyursolic Acid-Type Triterpenes from Peruvian “Una de Gato” (Uncaria tomentosa). (2000) (3)
- Sarcosine and Decreased Risk for Prostate Cancer in Schizophrenia (2009) (3)
- Food Coloring, Sodium Benzoate Preservative, and D-serine: Implications for Behavior (2011) (3)
- Early Intervention for Psychosis with N-Methyl-D-Aspartate Receptor Modulators (2015) (3)
- Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response (2021) (3)
- Understanding the link between maternal infections and neurodevelopmental disorders in offspring: The role of abnormalities in metabolism of polyunsaturated fatty acids (2019) (3)
- Effect of Intraoperative Esketamine Infusion on Postoperative Sleep Disturbance After Gynecological Laparoscopy (2022) (2)
- In Vivo Evaluation of 11C-labeled Three Radioligands for Glycine Transporter 1 in the Mouse Brain (2012) (2)
- CSF serine enantiomers and glycine in the study of neurologic and psychiatric disorders. (2008) (2)
- [Evaluation of 3H-paroxetine as a radiopharmaceutical for lung function]. (1989) (2)
- Targeting the sigma-1 receptor chaperone in the treatment of perinatal brain injury (2015) (2)
- Neonatal signs following exposure to SSRIs (2005) (2)
- Lack of neuroprotective effect of sigma receptor ligands in the neurotoxicity of p-chloroamphetamine in rat brain. (1996) (2)
- Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine (2021) (2)
- Neural rhythm in the retrosplenial cortex during ketamine-induced dissociation (2021) (2)
- Reply to: Minocycline, schizophrenia and GluR1 glutamate receptors (2009) (2)
- Effect of the acute and chronic administration of the putative atypical antipsychotic drug Y‐931 (8‐fluoro‐12‐ (4‐methylpiperazin‐1‐yl)‐6H‐[1]benzothieno[2,3b][1,5] benzodiazepine maleate) on spontaneously active rat midbrain dopamine neurons: An in vivo electrophysiological study (2004) (2)
- Efficacy and safety of perioperative application of ketamine on postoperative depression: A meta-analysis of randomized controlled studies (2023) (2)
- Ketamine and rapid-acting antidepressants : a new era in the battle against depression and suicide (2018) (2)
- Upregulation of heat-shock protein HSP-70 and glutamate transporter-1/glutamine synthetase in the striatum and hippocampus in haloperidol-induced dopamine-supersensitivity-state rats (2021) (2)
- A role of GABAA receptor α1 subunit in the hippocampus for rapid-acting antidepressant-like effects of ketamine (2022) (2)
- Effects of quetiapine on dizocilpine-induced prepulse inhibition deficits in mice: Possible role of the a α1 adrenergic receptor (2010) (2)
- Abnormalities in the brain–immune system in psychotic disorders: from pathogenesis to prevention (2017) (2)
- Effect of repetitive transcranial magnetic stimulation on the kynurenine pathway in stroke patients. (2020) (2)
- Relationship between Perception and Anxiety About COVID-19 Infection and Risk Behaviors for Spreading Infection: Preliminary Report of a National Survey in Japan (2020) (2)
- Effect of phencyclidine on endogenous excitatory amino acid release from the rat anterior cingulate cortex--an in vivo microdialysis study. (1993) (2)
- Frontiers in CNS Drug Discovery (2017) (2)
- Lithium augmentation in milnacipran-refractory depression for the prevention of relapse following electroconvulsive therapy. (2005) (2)
- Effect of phencyclidine on endogeneous excitatory amino acid release from the rat anterior cingulate cortex — an in vivo microdialysis study (1993) (2)
- Biomarkers for Alzheimer’s disease: from pathogenesis to drug development (2018) (2)
- Auditory sensory gating and inflammation as translational biomarkers of α7 nicotinic acetylcholine receptor agonists in the treatment of neuropsychiatric disorders (2015) (2)
- Impact of broad-spectrum antibiotics on the gut–microbiota–spleen–brain axis (2022) (2)
- Monoaminergic balances predict non-depression-like phenotype in Learned Helplessness Paradigm (2020) (2)
- Tropisetron for postoperative cognitive decline (2015) (2)
- Brain-Derived Neurotrophic Factor (BDNF): TrkB Signaling in Depression – Biomarker and Novel Therapeutic Target (2016) (2)
- Potential Role of the Sigma-1 Receptor Chaperone in the Beneficial Effects of Donepezil in Dementia with Lewy Bodies (2013) (1)
- Dopamine Receptors and Hippocampal Seizure Generation (1998) (1)
- Beneficial effects of arketamine on the reduced bone mineral density in susceptible mice after chronic social defeat stress: Role of the gut–microbiota–bone–brain axis (2023) (1)
- Effect of human serum on 3H-di-O-tolylguanidine (DTG) binding to rat cortical membrane (1992) (1)
- Genomic Triplication of the Glycine Decarboxylase Gene and N-Methyl-D-Aspartate Receptor Hypofunction: Improvement by Glycine and D-Cycloserine (2019) (1)
- New Synthesis of Isoquinoline and 3,4‐Dihydroisoquinoline Derivatives. (2006) (1)
- Correction: Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder (2013) (1)
- Minocycline and St. John’s Wort as Therapeutic Drugs for Human Tauopathy (2015) (1)
- Effects of Subdiaphragmatic Vagotomy in the MPTP-induced Neurotoxicity in the Striatum and Colon of Mice (2022) (1)
- PET studies in conscious monkeys of carbon-11-labeled N-((S)-1-((S)-1-methylpiperidin-2-yl)ethyl)acetamide derivatives as a potential radioligands for glycine transporter 1 (2010) (1)
- Corrigendum to “Increased serum levels of glutamate in adult patients with autism” [Progress in Neuro-Psychopharmacology & Biological Psychiatry 30 (2006) 1472--1477] (2007) (1)
- Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine (2011) (1)
- Familial Influences on Mismatch Negativity and Its Association with Plasma Glutamate Level: A Magnetoencephalographic Study in Twins (2016) (1)
- Corrigendum to "Prophylactic Effects of Sulforaphane on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation" Journal of Nutritional Biochemistry 39 (2017) 134-144. (2020) (1)
- Antidepressant Actions of Ketamine and Its Two Enantiomers (2020) (1)
- Analysis of strain-dependent prepulse inhibition points to a role for Shmt1 (SHMT1) in mice and in schizophrenia (2010) (1)
- Abnormal gene expression of BDNF, but not BDNF-AS, in iPSC, neural stem cells and postmortem brain samples from bipolar disorder. (2021) (1)
- A NEUROBIOLOGICAL MODEL OF MEMORY IMPAIRMENT IN LATE-LIFE MAJOR DEPRESSIVE DISORDER (2017) (1)
- Protective effects of neuropeptide S against MK-801-induced psychotic-like behavior and neuropathological changes (2006) (1)
- Synthesis of Functionalized Chromanes via a Formal [3 + 3]Cycloaddition of Allene Sulfonamides to Phenols. (2010) (1)
- [The neurobiological approaches to obsessive-compulsive disorder]. (2002) (1)
- Additional file 1: of The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial (2016) (1)
- Mental health during the COVID-19 pandemic, impact of childhood trauma in psychiatric disorders, and predictable biomarkers for bipolar disorder (2022) (1)
- Corrigendum to “(R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut–microbiota–brain axis” [Neurobiol Dis. 165 (2022):105635.] (2022) (1)
- The Glutamatergic System as Potential Clinical Biomarkers for Blood and Cerebrospinal Fluid Monitoring (2018) (1)
- Neuron Terminal Monoamines Related to Resilience, Depression-Like, or Non-Depression-Like Behavioral States in Learned Helplessness Paradigm. (2020) (1)
- Repeated use of 3,4-methylenedioxymethamphetamine is associated with the resilience in mice after chronic social defeat stress: A role of gut–microbiota–brain axis (2022) (1)
- Novel Therapeutic Drugs for Neuropsychiatric Disorders (2010) (1)
- In vivo study of drug interaction with brain benzodiazepine receptor (1985) (1)
- Reduction of dopamine and glycogen synthase kinase-3 signaling in rat striatum after continuous administration of haloperidol (2021) (1)
- Reply to Reeves and Dunn: Risk for autism in offspring after maternal glyphosate exposure (2020) (1)
- Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity (2022) (0)
- Supplementary Material for: Familial Influences on Mismatch Negativity and Its Association with Plasma Glutamate Level: A Magnetoencephalographic Study in Twins (2016) (0)
- Corrigendum to "Prophylactic Effects of Sulforaphane on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation" [Journal of Nutritional Biochemistry; 39(2017); 134-144]. (2020) (0)
- Glutamatergic system abnormalities in posttraumatic stress disorder (2015) (0)
- [Recent findings about biomarkers in the peripheral blood of drug abusers: mainly about BDNF and cytokine]. (2010) (0)
- Evaluating the cognitive decline in early-stage frontotemporal dementia (2009) (0)
- The pharmaceutical composition to treat tardive dyskinesia and its use (1996) (0)
- No changes of expression of GPR56 protein in the parietal cortex, cerebellum, and liver from psychiatric disorders (2021) (0)
- Radiosynthesis of [ 11 C]A-582941 and [ 11 C]A-844606. (2013) (0)
- CLOSE CORRELATION OF IN VIVO [3H]SCH23390 BINDING AND TEMPERATURE REVEALED BY RESERPINE AND ROLIPRAM TREATMENT (1992) (0)
- Role of EphA4 signaling in the pathogenesis of amyotrophic lateral sclerosis and therapeutic potential of traditional Chinese medicine rhynchophylline (2015) (0)
- Medicament for the treatment of schizophrenia comprising cilostazol (2008) (0)
- P.2.d.027 Serum glycine and serine levels in patients with bipolar disorder (2013) (0)
- Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats (2017) (0)
- Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression (2015) (0)
- Maternal Glyphosate Exposure Causes Autism‐like Behaviors in Offspring through Increased Expression of Soluble Epoxide Hydrolase (2020) (0)
- Pentylenetetrazole-induced seizure is attenuated in serine racemase knockout mice (2011) (0)
- PM429. Comparison of haloperidol and blonanserin on development of dopamine supersensitivity after chronic treatment (2016) (0)
- PHARMACEUTICAL APPLICATIONS FOR (S)-NORKETAMINE AND SALTS THEREOF (2018) (0)
- Author Correction: Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model (2018) (0)
- Agents for the treatment of psychotic diseases euro-Nazi (2005) (0)
- Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant (2016) (0)
- odulation of D-Serine Levels in Brains of Mice acking PICK 1 (2008) (0)
- Risk of esketamine anesthesia on the emergence delirium in preschool children after minor surgery: a prospective observational clinical study. (2023) (0)
- Primary researchSerum glutamine , set-shifting ability and anorexia nervosa (2015) (0)
- Differential effects of ketamine metabolites on depression-like behaviors induced by chronic corticosterone injection in mice (2020) (0)
- The following is a list of selected recently published Expert Opinion articles, related to the content of this issue of Expert Opinion on Therapeutic Targets (2014) (0)
- Ketamine and its metabolites: Potential as novel treatments for depression (2023) (0)
- Author Correction: Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model (2018) (0)
- Lack of Neuroprotective Effect of σ Receptor Ligands in the Neurotoxicity of p‐Chloroamphetamine in Rat Braina a (1996) (0)
- Pharmacological inhibition of soluble epoxide hydrolase alleviates chronic neuropathic pain induced anhedonia symptoms: differential role of AhR and TSPO signaling (2020) (0)
- DIFFERENCES OF PREPULSE INHIBITION BETWEEN C57BL/6 AND C3H/He MICE ARE ASSOCIATED WITH D-SERINE METABOLISM (2009) (0)
- [Progress in diagnosis of psychiatric diseases using blood samples--recent findings of brain-periphery interaction in drug abusers]. (2008) (0)
- A Key Role of Soluble Epoxide Hydrolase in the Pathogenesis of Parkinson's Disease (2018) (0)
- Radiosynthesis and biological evaluation of carbon-11-labeled N-((S)-1-((S)-1-methylpiperidin-2-yl)ethyl)acetamide derivatives as a potential radioligands for glycine transporter 1 (2010) (0)
- [Development of new therapeutic drugs based on the pathophysiology of schizophrenia]. (2011) (0)
- Estimating sigma-1 receptor occupancy by PET (2011) (0)
- The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling (2023) (0)
- 115. Mismatch Negativity in Patients with Early Stages of Psychosis and in Nonhuman Primate (2017) (0)
- Glycine Transport Inhibitors for the Treatment of Schizophrenia~!2009-09-10~!2009-09-21~!2010-05-27~! (2010) (0)
- Linking 5-hydroxytryptamine to antidepressant actions of (R)-ketamine and social stress model (2021) (0)
- An electrophotographic scanning (1976) (0)
- Explorer A novel balanced chromosomal translocation found in subjects with schizophrenia and schizotypal personality disorder : Altered L-serine level associated with disruption of PSAT 1 gene expression (2016) (0)
- [Aripiprazol potentiates NGF-induced neurite outgrowth]. (2013) (0)
- NDT_A_209319 1771..1779 (2019) (0)
- Sigma-1 receptor : A novel therapeutic target for neuropsychiatric diseases (2009) (0)
- Erratum: Figure Correction (2014) (0)
- Old drug ifenprodil, new hope for PTSD with a history of childhood abuse (2013) (0)
- Evaluating a novel alpha7 nicotinic acetylcholine receptor ligand [11C]CHIBA1001 for positron emission tomography (2010) (0)
- Aβ1–42-induced neurotoxicity is attenuated in the serine racemase knockout mice (2009) (0)
- Association between serum levels of glial cell line-derived neurotrophic factor and inattention in adult patients with attention deficits/hyperactivity disorder (2020) (0)
- On the Eve of Upgrading Antidepressants: (R)-Ketamine and Its Metabolites (2016) (0)
- Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammation (2016) (0)
- Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study (2017) (0)
- Complications and Trouble Shooting (1993) (0)
- REDUCTION OF D-SERINE IN NEONATAL MOUSE BRAIN CAUSED SCHIZOPHRENIA-LIKE BEHAVIORAL ABNORMALITIES IN ADULTHOOD : A NOVEL ANIMAL MODEL OF SCHIZOPHRENIA (2009) (0)
- Role of NMDA receptor GluN2D subunit in the antidepressant effects and the cognitive impairment effects of enantiomers of ketamine (2018) (0)
- Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation (2018) (0)
- Alterations in amino acid levels in mouse brain regions after adjunctive treatment of brexpiprazole with fluoxetine: comparison with (R)-ketamine (2017) (0)
- CogState Battery--Chinese Version (2015) (0)
- Peripheral nerve toxicology (1988) (0)
- Lack of correlation between phonetic magnetic mismatch field and plasma d-serine levels in humans (2018) (0)
- Loss of parvalbumin-positive cells in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine (2021) (0)
- Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression (2016) (0)
- Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model (2017) (0)
- A 32-case study where quetiapine therapy was continued following the issuance of a Dear Dr letter (2004) (0)
- Alterations in Plasma Levels of Amino Acids after Intracerebroventricular Administration of L-Serine or D-Serine in Conscious and Freely Moving Rats (2008) (0)
- Abnormal compositions of gut microbiota and metabolites are associated with susceptibility versus resilience in rats to inescapable electric stress. (2023) (0)
- Do you know the novel antidepressant arketamine? (2022) (0)
- Synthesis of (Z)‐2‐(2H‐Isoquinolin‐1‐ylidene)acetamides by Iodine‐Mediated Cyclization of (Z)‐3‐Amino‐3‐(2‐vinylphenyl)propenamides. (2007) (0)
- Synthesis of 4,5-Diaminopyrrolo[1,2-a]quinoline Derivatives by Annulation of N,N-Dialkyl[2-(pyrrol-1-yl)benzylidene]ammonium Salts in the Presence of an Isocyanide. (2007) (0)
- Synthesis of 1‐Aminonaphthalene‐2‐carbonitrile Derivatives by the Reaction of 2‐Vinylbenzonitriles with 2‐Lithioacetonitrile. (2008) (0)
- Synthesis of (Z)-2-[(Z)-3-Alkylideneisobenzofuran-1(3H)-ylidene]acetic Acid Derivatives by Sequential Coupling—Cyclization Between 3-(2-Iodophenyl)-3-oxopropanoic Acid Derivatives and Terminal Alkynes. (2008) (0)
- A Facile Synthesis of 9-Dialkylamino-9H-pyrrolo[1,2-a]indoles via Iminium Salts Generated from 2-(Pyrrol-1-yl)benzaldehydes and Secondary Amine Hydrochlorides in the Presence of NaI/TMSCl/Et3N. (2006) (0)
- Involvement of the agranular insular cortex in antidepressant actions of arketamine (2022) (0)
- Synthesis of 9,9‐Disubstituted 9H‐Pyrrolo[1,2‐a]indoles by Hydriodic Acid‐Catalyzed Cyclization of 1‐[2‐(1‐Aryl(or methyl)ethenyl)phenyl]‐1H‐pyrroles. (2011) (0)
- Increased EphA4-ephexin1 signaling in the medial prefrontal cortex plays a role in depression-like phenotype (2017) (0)
- Gold-Catalyzed Stereoselective Synthesis of Di- or Trisubstituted Olefins Possessing a 1,4-Diene Framework via Intramolecular Allylation of Alkynes. (2011) (0)
- A Facile Synthesis of 1,1-Disubstituted Isoindoline Derivatives by Intramolecular Iodoamination of 2-Vinylbenzylamine Derivatives. (2007) (0)
- Fries Rearrangement of Phenyl and Tolyl Diphenylacetates. (1991) (0)
- Gold‐Catalyzed Intermolecular Addition of Alcohols Toward the Allenic Bond of 4‐Vinylidene‐2‐oxazolidinones. (2009) (0)
- PM365. Effects of sulforaphane in the maternal immune activation model of schizophrenia (2016) (0)
- Mesenchymal stem-cell-derived microvesicles ameliorate MPTP-induced neurotoxicity in mice: a role of the gut–microbiota–brain axis (2023) (0)
- A process for the alkylation of the ortho-position of phenolic compounds (1975) (0)
- Alterations in in-vivo benzodiazepine-receptor binding of C-11-Ro15-1788 (flumazepil) (1985) (0)
- M16. PROFILING GLUTAMATE AND D-SERINE PATHWAYS IN TREATMENT RESISTANT EARLY PSYCHOSIS PATIENTS (2020) (0)
- Poster #15 SULFORAPHANE AS A POTENTIAL THERAPEUTIC DRUG FOR SCHIZOPHRENIA (2012) (0)
- Overview of the potential use of fluvoxamine for COVID-19 and long COVID (2023) (0)
- [Preclinical evaluation of the 11C-Ro 15-1788 solution for injection as a radiopharmaceutical]. (1985) (0)
- Increased serum levels of serine enantiomers in patients with depression – ERRATUM (2015) (0)
- Sex-Specific Differences in the Transcriptome of the Human Dorsolateral Prefrontal Cortex in Schizophrenia (2022) (0)
- Quantitative analysis of the dynamic change of ligand-receptor binding. (1991) (0)
- Editorial: Cognitive Enhancement in Psychiatric Disorders (2019) (0)
- Novel potential therapeutic approaches for schizophrenia. (2011) (0)
- [Measurement of serotonin uptake site in the human brain using PET]. (1991) (0)
- reportFluvoxamine for blonanserin-associated akathisia in patients with schizophrenia : report of five cases (2015) (0)
- Special issue on “Brain–body communication in health and diseases” (2022) (0)
- Differential levels of brain amino acids in rat models presenting learned helplessness or non-learned helplessness (2013) (0)
- Alterations in the inflammatory cytokines and brain-derived neurotrophic factor contribute to depression-like phenotype after spared nerve injury: improvement by ketamine (2017) (0)
- reportSigma-1 receptor agonist fluvoxamine for delirium in intensive care units : report of five cases (2015) (0)
- Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model (2018) (0)
- Blood d-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine (2014) (0)
- Contents Vol. 71, 2015 (2015) (0)
- [Study on the measurement of free ligand concentration in blood and quantitative analysis of brain benzodiazepine receptors]. (1988) (0)
- [JSNP Excellent Presentation Award for CINP2014]. (2017) (0)
- [JSNP Excellent Presentation Award for CINP2014]. (2015) (0)
- Reduced Mismatch Negativity is Associated with Increased Plasma Level of Glutamate in First-episode Psychosis (2017) (0)
- Depression-like behaviors in mouse model of Sjögren's syndrome: A role of gut–microbiota–brain axis (2022) (0)
- Correction: Fecal microbiota transplantation from patients with rheumatoid arthritis causes depression-like behaviors in mice through abnormal T cells activation (2022) (0)
- Effectiveness of Enteral Formula with Enriched Polyunsaturated Fatty Acids in the Treatment of Anorexia Nervosa: A Pilot Open Case Study (2012) (0)
- Antibiotic-Induced Microbiome Depletion Is Associated with Resilience in Mice after Chronic Social Defeat Stress (2019) (0)
- [Biomarkers for Mood Disorders and a Novel Antidepressant (R)-ketamine]. (2017) (0)
- Corrigendum to “Key role of the gut–microbiota–brain axis via the subdiaphragmatic vagus nerve in demyelination of cuprizone-treated mouse brain” [Neurobiology of Disease 176 (2023); 105961. doi: 10.1016/j.nbd.2022.105951] (2023) (0)
- Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model (2018) (0)
- Consecutive increment of serum alpha-feto protein level is a useful surrogate marker in predicting hepatocellular carcinoma in liver cirrhosis patients (2014) (0)
- Editorial [Hot topic:Novel Potential Therapeutic Approaches for Schizophrenia (Executive Guest Editor: Kenji Hashimoto)] (2011) (0)
- MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling (2019) (0)
- Open Access PRIMARY RESEARCH (2010) (0)
- Review for "Gut‐microbiota‐brain axis in depression: The role of neuroinflammation" (2019) (0)
- Reviews of "Inhibition of SARS-CoV-2 infection in human cardiomyocytes by targeting the Sigma-1 receptor disrupts cytoskeleton architecture and contractility" (2021) (0)
- Reversal of the detrimental effects of social isolation on ischemic cerebral injury and stroke-associated pneumonia by inhibiting small intestinal γδ T-cell migration into the brain and lung. (2023) (0)
- Corrigendum to “An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients” (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Kenji Hashimoto?
Kenji Hashimoto is affiliated with the following schools:
